XTX Topco Ltd - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 116 filers reported holding OCULAR THERAPEUTIX INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q4 2022$665,551
+206.7%
236,851
+353.2%
0.14%
+161.1%
Q3 2022$217,000
+138.5%
52,266
+131.6%
0.05%
+45.9%
Q2 2022$91,000
-48.6%
22,568
-36.9%
0.04%
-52.6%
Q1 2022$177,000
+108.2%
35,767
+193.5%
0.08%
+62.5%
Q4 2021$85,000
-74.1%
12,185
-47.3%
0.05%
-56.8%
Q2 2021$328,00023,1210.11%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q4 2022
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$31,590100.00%
Opaleye Management Inc. 5,780,000$29,824,8007.13%
DELTEC ASSET MANAGEMENT LLC 1,974,797$10,189,9532.23%
Lynwood Capital Management Inc. 262,500$1,354,5001.72%
Endurant Capital Management LP 368,438$1,901,1401.66%
Knoll Capital Management, LLC 200,000$1,032,0001.25%
Knoll Capital Management, LLC 95,800$814,3000.99%
SECTORAL ASSET MANAGEMENT INC 802,680$4,141,8290.69%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,977$1,553,0410.22%
Cormorant Asset Management, LP 645,000$3,328,2000.19%
View complete list of OCULAR THERAPEUTIX INC shareholders